About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Genetic Collection Protocol | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT05272319

Genetic Collection Protocol

This study involves the one-time collection of whole blood or saliva samples for the extraction and storage of DNA for use in ongoing and future ChiLDReN studies.

Lead sponsor: Arbor Research Collaborative for Health•12 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Terese A Howell, BS

CONTACT

734-476-5340 terri.howell@aborresearch.org

Melissa Sexton, BBA

CONTACT

734-693-3811 melissa.sexton@arborresearch.org

Sponsors

Lead Sponsor

Arbor Research Collaborative for Health

The purpose of this study is to establish a mechanism to collect a genetic biosample from the participants previously enrolled into clinical research under ChiLDReN-supported protocols (PROBE and BASIC). The samples will be linked to the data previously collected on the participant. Samples will be stored in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) specimen repository and will be used in ongoing and future Network and Ancillary Studies of ChiLDReN to further address the pathophysiology and outcomes of these liver diseases.

Age

0 - 25 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•For Child Participants
•1. Previous enrollment in PROBE or BASIC
•2. Exited from one of the aforementioned studies.
•3. Consent for DNA sample collection obtained during enrollment during enrollment to one of the aforementioned studies but sample not previously collected.
•4. Still followed at the clinical site.

Exclusion Criteria

•
•1. Participant is deceased
•2. Participant exited from prior study due to violating eligibility criteria
•3. Participant cannot be contacted

Related studies

DILIN - Prospective Study

NCT00345930 · Liver Diseases

RECRUITINGPhase 2

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

NCT06613698 · Liver Diseases, Alcoholic

Development of a FibroScan Liver Examination Using a Single Probe

NCT07400289 · Liver Diseases

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

NCT05264051 · Liver Diseases

Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled Trial

NCT06493773 · Liver Diseases, Alcoholic, Alcohol Use Disorder, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 10, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment2,230

Start dateApr 2022

Last updatedSep 10, 2025

Condition

Locations shown

Children's Hospital of Los Angeles

Los Angeles, California

UCSF Benioff Children's Hospital

San Francisco, California

Children's Hospital Colorado

Aurora, Colorado

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 10, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions